• About us
  • Contact us
  • Home
  • Privacy Policy
  • Terms & Conditions
  • Thank you
Profit News Report
No Result
View All Result
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
No Result
View All Result
Profit News Report
No Result
View All Result
Home Editor's Pick

Gabbard says declassified biolab records validate concerns previously dismissed as misinformation

by
June 15, 2026
in Editor's Pick
0
Gabbard says declassified biolab records validate concerns previously dismissed as misinformation
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Director of National Intelligence Tulsi Gabbard released a trove of declassified records detailing U.S. funding of more than 120 biological laboratories across more than 30 countries, arguing the documents validate concerns that were previously dismissed as misinformation.

The release comes years after Gabbard drew criticism for raising concerns about U.S.-funded biolabs in Ukraine following Russia’s 2022 invasion. Critics accused her of echoing Russian narratives, while supporters argued legitimate questions about the labs’ activities and oversight were being unfairly dismissed.

The newly released records include ODNI briefing slides detailing the scope of U.S. involvement in Ukraine’s laboratory network.

DNI TULSI GABBARD PROBES U.S. FUNDING TO MORE THAN 120 BIOLABS AROUND THE WORLD

One document states that more than 40 laboratories in Ukraine received U.S. funding and housed collections of dangerous bacteria and viruses, some dating back to the Soviet era. The records also show Ukrainian scientists received U.S.-funded training to work with hazardous pathogens and participated in a program focused on handling especially dangerous diseases.

The documents list pathogens studied or stored within the laboratory network, including anthrax, tuberculosis, plague, Ebola virus, Marburg virus, MERS and SARS.

Additional records detail U.S.-funded construction and upgrades at laboratories across Ukraine, including facilities in Kherson, Odesa and western Ukraine. The documents identify engineering firm Black & Veatch as a major contractor and show U.S. taxpayers spent between roughly $1.7 million and $3.5 million on individual laboratory projects.

LAWMAKERS DEMAND ANSWERS AFTER SUSPECTED BIOLAB DISCOVERED IN CHINESE NATIONAL’S LAS VEGAS HOME

One declassified assessment focuses on a veterinary research laboratory in Kharkiv that received Pentagon funding through the Defense Department’s Biological Threat Reduction Program.

According to the assessment, the facility housed hundreds of samples of dangerous pathogens, including Brucella bacteria, which can cause a disease known as brucellosis. The document warned the lab could become a target of Russian propaganda efforts or be damaged, captured or otherwise compromised during the war.

Another ODNI slide outlines what it describes as a “web of connections” linking Ukrainian laboratories with U.S. government agencies, universities, research organizations and private contractors. The document says U.S. funding supported research on bird flu and other highly infectious viruses in high-security laboratories.

Gabbard said the documents demonstrate that the public was not given a full picture of U.S.-backed biological research programs overseas. Critics, however, maintain the facilities were part of long-running public health and threat-reduction efforts designed to secure dangerous pathogens and prevent biological proliferation rather than operate as biological weapons programs.

The declassification is likely to reignite debate over government transparency, gain-of-function research and the scope of U.S.-funded biological research overseas.

<!–>

–>

Previous Post

Party Poopers’ Fight Card: Jane Fonda, ‘No Kings,’ communists roll out rival spectacle to Trump’s 250th

Next Post

Trump marks 80th birthday, now second octogenarian sitting president: ‘Seemed to utterly defy age’

Next Post
Dow futures surge 430 points: 5 things to know before Wall Street opens

Dow futures surge 430 points: 5 things to know before Wall Street opens

  • Trending
  • Comments
  • Latest
Dell falls as UBS warns explosive AI-driven gains may be peaking; downgrades stock

Dell falls as UBS warns explosive AI-driven gains may be peaking; downgrades stock

May 11, 2026
Why Alphabet stock is outperforming broader market today?

Why Alphabet stock is outperforming broader market today?

May 13, 2026
Coherent Lumentum stocks continues surge: how high can the AI trade go

Coherent Lumentum stocks continues surge: how high can the AI trade go

May 13, 2026
USA Rare Earth stock dips: why analysts are still bullish on the stock

USA Rare Earth stock dips: why analysts are still bullish on the stock

May 14, 2026
Western Digital stock surges as Morgan Stanley lifts target to $650

Western Digital stock surges as Morgan Stanley lifts target to $650

0
Tata Consumer shares hit 2-year high as analysts back strong growth outlook

Tata Consumer shares hit 2-year high as analysts back strong growth outlook

0
Is Wall Street becoming too dependent on AI-driven market gains?

Is Wall Street becoming too dependent on AI-driven market gains?

0
FTSE 100 edges higher as oil risks keep European markets cautious

FTSE 100 edges higher as oil risks keep European markets cautious

0
Western Digital stock surges as Morgan Stanley lifts target to $650

Western Digital stock surges as Morgan Stanley lifts target to $650

June 15, 2026
Strategy (MSTR) stock rises as Bitcoin buy eases fears of liquidation risk

Strategy (MSTR) stock rises as Bitcoin buy eases fears of liquidation risk

June 15, 2026
SpaceX stock: prediction markets suggest it will fail to hit key milestone by 2030

SpaceX stock: prediction markets suggest it will fail to hit key milestone by 2030

June 15, 2026
What’s driving Rolls-Royce stock higher today?

What’s driving Rolls-Royce stock higher today?

June 15, 2026

Recent News

Western Digital stock surges as Morgan Stanley lifts target to $650

Western Digital stock surges as Morgan Stanley lifts target to $650

June 15, 2026
Strategy (MSTR) stock rises as Bitcoin buy eases fears of liquidation risk

Strategy (MSTR) stock rises as Bitcoin buy eases fears of liquidation risk

June 15, 2026
SpaceX stock: prediction markets suggest it will fail to hit key milestone by 2030

SpaceX stock: prediction markets suggest it will fail to hit key milestone by 2030

June 15, 2026
What’s driving Rolls-Royce stock higher today?

What’s driving Rolls-Royce stock higher today?

June 15, 2026
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Disclaimer: Profitnewsreport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2026 Profitnewsreport.com

No Result
View All Result
  • About us
  • Contact us
  • Home
  • Privacy Policy
  • Terms & Conditions
  • Thank you

Disclaimer: Profitnewsreport.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2026 Profitnewsreport.com